首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1110092

成人疫苗市场：按疫苗、疫苗类型、技术、地区 - 规模、份额、前景、机会分析，2022-2030

Adult Vaccines Market, by Vaccine, by Vaccine Type, by Technology, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年07月08日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3个工作天内

价格

简介目录

疫苗是提高免疫力以对抗某些疾病的生物製剂。疫苗由减毒、杀死或破碎的微生物、毒素或抗体製成的悬浮液组成，主要用于预防疾病的患者。疫苗通过刺激免疫系统攻击它们来提供针对特定有害或致病因子的主动免疫。疫苗有助于保护患者免受流感和麻疹等严重和致命疾病的侵害。成人免疫接种：适用于 18 岁及以上的患者，包括使用许可用于医疗适应症的疫苗。常规接种疫苗是为了消除婴儿和儿童的传染病，但美国疾病控制和预防中心 (CDC) 2017 年将其称为成人疫苗，建议成人也定期接种疫苗。根据 CDC 2015 年的数据，美国 2020 年健康人使命计划中 30% 的患者选择了带状疱疹疫苗，并报告说可以预防可预防的疾病。成人疫苗接种给 18 岁及以上的人。

市场动态

市场参与者越来越专注于开发针对最有可能像流行病一样传播的疾病的疫苗。例如，2017 年 2 月，总部位于印度的製药公司 Cipla 与印度血清研究所合作，为该国的成年人推出了乙型肝炎疫苗。根据印度的普遍免疫计划，该疾病在 2018 年长期影响该国超过 4000 万人。此外，生物製药公司 Dynavax Technologies Corporation 于 2018 年获得美国食品药品监督管理局 (U.S.FDA) 的批准，该疫苗适用于 18 岁及以上成人的两剂乙型肝炎疫苗。

本研究的主要特点

本报告对全球成人疫苗市场进行了深入分析，提供了以 2021 年为基准年的预测期间（2022-2030 年）的市场规模和復合年增长率 (CAGR%) 的增长。
解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
该研究还提供了有关市场驱动因素、抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
基于公司亮点、产品组合、关键亮点、财务业绩和战略等参数的全球成人疫苗市场主要参与者的概况。
本次调查涵盖的主要公司包括葛兰素史克公司、默克公司、赛诺菲巴斯德公司、辉瑞公司、CSL 有限公司、强生公司、印度血清研究所、Medimmune 和阿斯利康公司。
本报告中的见解将使营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球成人疫苗市场报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
用于分析全球成人疫苗市场的各种战略矩阵将有助于利益相关者做出决策。

内容

第 1 章目的和先决条件

调查目的
先决条件
缩写说明

第2章市场展望

举报内容
- 市场定义和范围
执行摘要
- 市场快照：按疫苗分类
- 市场快照：按疫苗类型
- 市场概览：按技术分类
- 市场概况：按地区划分
连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

市场动态
- 驱动程序
- 限制因素
- 市场机会
主要亮点
市场趋势
PEST 分析
政府和非政府举措
流行病学

第 4 章全球成人疫苗市场 - COVID-19 影响分析

整体影响
政府举措
COVID-19 对市场的影响

第 5 章全球成人疫苗市场，按疫苗，2017-2030 年

流感
破伤风、白喉、百日咳 (Td/Tdap)
水痘
人乳头瘤病毒
带状疱疹
麻疹、腮腺炎、风疹 (MMR)
肺炎球菌
肝炎
其他

第 6 章按疫苗类型分列的成人疫苗全球市场（2017-2030 年

单价疫苗
多价疫苗

第 7 章全球成人疫苗市场：按技术，2017-2030 年

2022 年和 2030 年市场份额分析 (%)
2018-20230 年同比增长分析
细分趋势

减毒活疫苗
- 2017-2030 年市场规模、预测、同比增长率
灭活□□病毒/细菌疫苗
- 2017-2030 年市场规模、预测和同比增长率
类毒素疫苗
- 市场规模及预测，2017 年至 2030 年的同比增长率
重组疫苗
- 市场规模及预测，2017-2030 年同比增长率
结合疫苗
- 2017-2030 年市场规模和预测，同比增长率

第 8 章按地区分列的成人疫苗全球市场，2017-2030 年

北美
美国
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地区
欧洲
英国
德国
意大利
法国
西班牙
俄罗斯
其他欧洲
亚太地区
中国
印度
日本
东盟
澳大利亚
韩国
其他亚太地区
中东
海合会
以色列
其他中东地区
非洲
北非
中非
南非

第 9 章竞争格局

热图分析
市场份额分析
公司简介
- GlaxoSmithKline Plc
- Merck & Co., Inc.
- Sanofi Pasteur
- Pfizer, Inc.
- CSL Limited
- Johnson & Johnson
- Serum Institute of India
- Medimmune
- AstraZeneca Plc.

第10章章节

调查手法介绍
关于出版社

简介目录

Product Code: CMI1091

Vaccines refer to the biological preparation that improves immunity to fight against a particular disease. Vaccines comprise suspensions formulated from weakened, killed or fragmented microorganisms, toxins or antibodies that are administered to a patient, with a primary intention to prevent a disease. Vaccines offer active immunity against specific harmful and disease causing agents by stimulating the immune system to attack the agent. Vaccines helps to protect individuals against serious and fatal diseases such as influenza and measles among others. Adult immunization that includes administration of licensed vaccine provided to patients aged 18 years and older, for medical indications. Vaccines are routinely administered to eliminate the infectious diseases among infants and children, however the Centers of Disease Control & Prevention (CDC), 2017, also recommends adults to periodically take up vaccination, referred to as adult vaccines. According to the CDC 2015, 30% of the patients from mission Healthy People program in the U.S. 2020 opted for shingles vaccine and were reported to be safe from preventable illness. Adult vaccines are given to age group to 18 year old and above.

Market Dynamics

Market players are increasingly focusing on creating vaccinations for illnesses having the highest risk of spreading like an epidemic. For instance, in February 2017, an India-based drug firm, Cipla, in collaboration with Serum Institute of India, introduced Hepatitis B vaccine for adults in the country. The disease affects chronically over 40 million people in 2018 in the country, as per India's Universal Immunization Program. Moreover, Dynavax Technologies Corporation, Biopharmaceutical Company received the United States Food and Drug Administration (U.S.FDA) approval in 2018, for its two-dosed Hepatitis-B vaccine indicated for adults aged 18 years and older.

Key features of the study:

This report provides an in-depth analysis of the global adult vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adult vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GlaxoSmithKline Plc, Merck & Co., Sanofi Pasteur, Pfizer, Inc., CSL Limited, Johnson & Johnson, Serum Institute of India, Medimmune, and AstraZeneca Plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global adult vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adult vaccines market

Detailed Segmentation:

Global Adult Vaccines Market, By Vaccines:
- Influenza
- Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Varicella
- Human Papillomavirus
- Zoster
- Measles, Mumps, Rubella (MMR)
- Pneumococcal
- Hepatitis
- Others
Global Adult Vaccines Market, By Vaccine Type:
- Monovalent
- Multivalent
Global Adult Vaccines Market, By Technology:
- Live Attenuated Vaccines
- Inactivated Viral/Bacterial Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Conjugate Vaccines
Global Adult Vaccines Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- GlaxoSmithKline Plc *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Merck & Co., Inc.
- Sanofi Pasteur
- Pfizer, Inc.
- CSL Limited
- Johnson & Johnson
- Serum Institute of India
- Medimmune
- AstraZeneca Plc.

"" marked represents similar segmentation in other categories in the respective section.*

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Vaccine Type
- Market Snapshot, By Technology
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Key Highlights
Market Trends
PEST Analysis
Government & Non-Government Initiatives
Epidemiology

4. Global Adult Vaccines Market- COVID-19 Impact Analysis

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Adult Vaccines Market, By Vaccine, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Influenza
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Tetanus, Diphtheria, Pertussis (Td/Tdap)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Varicella
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Human Papillomavirus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Zoster
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Measles, Mumps, Rubella (MMR)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Pneumococcal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Hepatitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2025, (US$ Million)

6. Global Adult Vaccines Market, By Vaccine Type , 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Monovalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Multivalent
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Adult Vaccines Market, By Technology, 2017 - 2030, (US$ Million)

Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 20230
Segment Trends

Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Inactivated Viral/Bacterial Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Million)

8. Global Adult Vaccines Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
UK
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type , 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa